HMOX1 and cardiomyopathy: HO-1 overexpression has shown to protect against doxorubicin-induced cardiomyopathy through induction of the PINK1 and Parkin expression, whereas HO-1 deficiency resulted in failure to upregulate PINK1 and Parkin-mediated mitophagy40,41.